Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Cidara Therapeutics Q4 EPS $(0.04) Beats $(0.10) Estimate, Sales $17.58M Beat $11.54M Estimate

Author: Benzinga Newsdesk | April 22, 2024 05:12pm

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.10) by 60 percent. This is a 78.95 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $17.58 million which beat the analyst consensus estimate of $11.54 million by 52.37 percent. This is a 72.06 percent increase over sales of $10.22 million the same period last year.

Posted In: CDTX